List view / Grid view
21 September 2015 | By Victoria White
DARPA is to provide the additional $24 million after Inovio successfully completed certain preclinical and clinical development milestones relating to the Ebola treatment programme...
18 August 2015 | By The European Antibody Congress
The European Antibody Congress takes place 9-11 November 2015 at the Congress Centre, Basel...
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
4 August 2015 | By Victoria White
For vaccine development, financial barriers persist: pharma companies see high costs with limited market potential, and government support is lacking...
30 July 2015 | By Victoria White
Inovio’s DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice...
21 July 2015 | By Victoria White
Emergent BioSolutions has been awarded a BARDA contract valued at $19.7 million to develop and manufacture three Ebola monoclonal antibodies...
30 June 2015 | By Victoria White
A study has demonstrated that Veloci-technologies enabled rapid identification and validation of potential candidates that could be developed to treat MERS...
29 June 2015 | By Victoria White
A study led by scientists at The Scripps Research Institute has identified new immune molecules that protect against Marburg virus, a relative of Ebola...
26 June 2015 | By Victoria White
A new study by scientists from the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before...
18 June 2015 | By Victoria White
The Ebola virus responsible for the outbreak in West Africa mutated at a similar rate to previous outbreaks, according to a new study led by PHE...
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
11 May 2015 | By Victoria White
Hemispherx Biopharma has received formal notification approving its Orphan Medicinal Product Application for Ampligen for the treatment of Ebola...
8 April 2015 | By Victoria White
Inovio has been selected to receive a grant from DARPA to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola...
